N-acetyltransferase 9

NAT9
Identifiers
AliasesNAT9, EBSP, hNATL, N-acetyltransferase 9 (putative)
External IDsOMIM: 620913; MGI: 1913426; GeneCards: NAT9
Enzyme activity
EC #BRENDAExPASyKEGGMetaCyc
2.3.1.308↗↗↗↗
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_025400

RefSeq (protein)

NP_079676
NP_001349818
NP_001349819
NP_001349820
NP_001349821

Location (UCSC)Chr 17: 74.77 – 74.78 MbChr 11: 115.18 – 115.19 Mb
PubMed search
Wikidata
View/Edit HumanView/Edit Mouse

Alpha/beta-tubulin-N-acetyltransferase 9, also called N-acetyltransferase 9 (NAT9), is an enzyme that in humans is encoded by the NAT9 gene. The enzyme functions to acetylate the proteins alpha- and beta-tubulin at N-terminal residues. In particular, it catalyzes the following reaction (EC 2.3.1.308):

N-terminal L-methionyl-[tubulin] + acetyl-CoA = N-terminal N(alpha)-acetyl-L-methionyl-[tubulin] + CoA + H+

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000109065 – Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000015542 – Ensembl, May 2017
  3. ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ↑ Helms C, Cao L, Krueger JG, Wijsman EM, Chamian F, Gordon D, Heffernan M, Daw JA, Robarge J, Ott J, Kwok PY, Menter A, Bowcock AM (Dec 2003). "A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis". Nat Genet. 35 (4): 349–56. doi:10.1038/ng1268. PMID 14608357. S2CID 22368199.
  6. ↑ "Entrez Gene: NAT9 N-acetyltransferase 9".
  7. ↑ "Alpha/beta-tubulin-N-acetyltransferase 9". UniProt consortium. Retrieved 2026-10-08.

Further reading